Home Stock

Stock Research: Max Healthcare Institute

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Max Healthcare Institute

NSI:MAXHEALTH INE027H01010
28
  • Value
    3
  • Growth
    99
  • Safety
    Safety
    43
  • Combined
    43
  • Sentiment
    14
  • 360° View
    360° View
    28
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Max Healthcare Institute Limited is an India-based integrated healthcare provider specializing in advanced cardiac care, orthopedics, oncology, neurosciences, and more, also offering outpatient and diagnostic services through Max Lab and Max@Home. It operates across Delhi NCR, Haryana, Punjab, Uttarakhand, Maharashtra, and Uttar Pradesh. In the last fiscal year, the company had 15114 employees, a market cap of $14319 million, profits of $636 million, and revenue of $823 million.

more

ANALYSIS: With an Obermatt 360° View of 28 (better than 28% compared with alternatives), overall professional sentiment and financial characteristics for the stock Max Healthcare Institute are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Max Healthcare Institute. The consolidated Growth Rank has a good rank of 99, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 99% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 3 means that the share price of Max Healthcare Institute is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 97% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 43, which means that the company has a riskier financing structure than 57% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 14, indicating professional investors are more pessimistic about the stock than for 86% of alternative investment opportunities. ...read more

more
Strongest Rank Value
Weakest Rank Revenue Growth
Country India
Industry Health Care Facilities
Size Large
Website maxhealthcare.in
Index
Robotics
Max Healthcare Institute stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
3 3 6 7
Growth
99 79 97 99
Safety
Safety
43 46 58 24
Sentiment
14 55 63 32
360° View
360° View
28 34 67 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
35 53 59 100
Opinions Change
40 43 59 50
Pro Holdings
n/a 74 39 1
Market Pulse
5 66 74 33
Sentiment
14 55 63 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
3 3 6 7
Growth
99 79 97 99
Safety Safety
43 46 58 24
Combined
43 26 65 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
7 3 7 17
Price vs. Earnings (P/E)
7 7 12 22
Price vs. Book (P/B)
10 12 24 26
Dividend Yield
43 14 12 1
Value
3 3 6 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
100 94 89 53
Profit Growth
82 65 44 100
Capital Growth
84 27 95 91
Stock Returns
51 81 89 100
Growth
99 79 97 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
47 52 68 60
Refinancing
24 11 23 17
Liquidity
48 72 61 16
Safety Safety
43 46 58 24

Similar Stocks

Discover high‑ranked alternatives to Max Healthcare Institute and broaden your portfolio horizons.

SBI Life Insurance

NSI:SBILIFE
Country: India
Industry: Life & Health Insurance
Size: Large
Full Stock Analysis

Ramkhamhaeng Hospital

SET:RAM
Country: Thailand
Industry: Health Care Facilities
Size: Medium
Full Stock Analysis

CESC

NSI:CESC
Country: India
Industry: Electric Utilities
Size: Medium
Full Stock Analysis

Bumrungrad Hospital

SET:BH
Country: Thailand
Industry: Health Care Facilities
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews